Inherited Retinal Disease Global Forecast: Market to Scale Up to $18.61 Billion by 2030 at 8.2% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the inherited retinal disease market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Inherited Retinal Disease Market in 2026, and what figure is it projected to hit by 2030?
The inherited retinal disease market has experienced robust expansion in recent years. This market is projected to expand from $12.54 billion in 2025 to $13.6 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.4%. The historical growth of this market is attributable to the identification of disease-causing retinal genes, advancements in retinal imaging technologies, increased awareness of inherited eye disorders, the growth of specialized ophthalmology clinics, and public and private funding for rare disease research.
The inherited retinal disease market is projected to experience substantial expansion, reaching $18.62 billion by 2030 with a compound annual growth rate (CAGR) of 8.2%. This anticipated growth is largely due to progress in gene therapy platforms, an increase in approvals for new retinal treatments, wider availability of genetic screening programs, the extension of precision medicine efforts, and rising investments in rare ophthalmic disease research and development. Key trends expected during this period involve the increasing use of genetic testing for early detection, a greater emphasis on gene and cell-based therapeutic options, the broadening of personalized treatment strategies, an uptick in clinical trials for uncommon retinal conditions, and enhanced patient access to sophisticated retinal imaging techniques.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp
Which Drivers Are Affecting Market Participation In The Inherited Retinal Disease Market?
The growing occurrence of macular degeneration is projected to drive the expansion of the inherited retinal disease market in the future. Macular degeneration is an ocular condition linked to aging that harms the macula, resulting in the loss of central vision and challenges with tasks like reading or identifying faces. This rising prevalence of macular degeneration stems from factors such as an aging demographic, extended life expectancy, and lifestyle elements like smoking and inadequate nutrition, all of which heighten the risk. Treatments for inherited retinal diseases assist patients with macular degeneration by addressing the fundamental genetic origins of retinal degeneration. These therapies offer methods to decelerate disease progression, recover lost vision, or even avert additional damage to the retina, thereby enhancing visual results and the overall quality of life for those impacted by age-related or inherited types of macular degeneration. For example, in February 2024, the Canadian Ophthalmological Society, a nonprofit organization based in Canada, indicated that 2.5 million people in Canada above 55 years old experience vision loss due to age-related macular degeneration (AMD). Consequently, the rising incidence of macular degeneration is fueling the expansion of the inherited retinal disease market.
What Segment Categories Are Covered In The Inherited Retinal Disease Market?
The inherited retinal disease market covered in this report is segmented –
1) By Type: Diagnosis, Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rod Dystrophy, Leber Congenital Amaurosis, Other Diseases
3) By Distribution Channel: Retail Sales, Direct Tender
4) By End User: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users
Subsegments:
1) By Diagnosis: Genetic Testing, Retinal Imaging, Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy, Photoreceptor Rescue Therapy
Which Competitive Trends Are Impacting The Structure Of The Inherited Retinal Disease Market?
Leading firms within the inherited retinal diseases market are concentrating on creating cutting-edge treatments, including mutation-agnostic gene therapy, aiming to deliver comprehensive therapeutic choices and tackle a broader spectrum of genetic mutations linked to these ailments. This form of gene therapy operates by targeting general genetic mechanisms or biological pathways instead of precise mutations, thereby proving useful across a variety of genetic conditions. As an illustration, in March 2024, Nanoscope Therapeutics Inc, a biotechnology firm based in the US, reported favorable outcomes from a clinical trial involving its primary program, MCO-010, which revealed enhancements in vision for individuals suffering from permanent and severe sight loss due to advanced retinitis pigmentosa. MCO-010 successfully met its main and crucial secondary objectives with statistical validity and without any significant adverse reactions.
Which Key Players Are Driving Competition In The Inherited Retinal Disease Market?
Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report
Which Region Currently Holds The Largest Share Of The Inherited Retinal Disease Market?
North America was the largest region in the inherited retinal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Inherited Retinal Disease Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp
Browse Through More Reports Similar to the Global Inherited Retinal Disease Market 2026, By The Business Research Company
Anemia And Other Blood Disorder Drugs Market Report 2026
Retinal Biologics Market Report 2026
https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report
Age Related Macular Degeneration Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
